Abstract
An observational study was established in South Africa in 2009, early in the influenza A(H1N1)pdm09 outbreak, to provide information on the virological response of the new virus to oseltamivir and the potential for resistance. Patients (n = 54) aged 1-64 years who were treated with standard five-day courses of oseltamivir, starting within two days of onset of the symptoms, showed rapid reductions in viral load or shedding and clinical signs and symptoms. Oseltamivir was well tolerated, with no serious adverse events. Signs of treatment-emergent phenotypic and genotypic resistance were noted in one patient.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Southern African Journal of Epidemiology and Infection
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
